← Back to Analyst Consensus 
NBTX Buy
Nanobiotix S.A.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 4, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| May 1, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 2, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Feb 6, 2026 | Guggenheim | maintain | Buy → Buy | $26 | 52% |
| Apr 4, 2025 | Guggenheim | maintain | Buy → Buy | $8 | 52% |
| Aug 28, 2024 | Guggenheim | initiate | — → Buy | $12 | 52% |
| Dec 8, 2023 | Leerink Partners | initiate | — → Outperform | $11 | 51% |
| Jan 6, 2021 | Evercore ISI Group | initiate | — → Outperform | $0 | 58% |
Price Target Trend
Apr 7, 2026 Oct 27, 2026
EPS Estimates
0y —
0q —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days